The National Comprehensive Cancer Network Oncology Research Program and Pfizer Global Medical Grants said they have awarded funding to nine projects that use clinical care pathways to implement quality improvement initiatives along the continuum of care for underserved patients with breast cancer.
Ronald Maier, the Jane and Donald D. Trunkey Endowed Chair in Trauma Surgery, vice-chairman, department of surgery, and professor of surgery, University of Washington School of Medicine, Seattle, was elected president-elect of the American College of Surgeons at the College's Annual Business Meeting held last month during its 2017 Clinical Congress in San Diego.
Leigh Neumayer was elected chair of the board of regents of the American College of Surgeons during the College's annual Clinical Congress, held in San Diego, Calif.
FDA has approved the FoundationOne CDx, the first breakthrough-designated, next generation sequencing-based in vitro diagnostic test that can detect genetic mutations in 324 genes and two genomic signatures in any solid tumor type.
NCI needs to focus on developing a structured approach to Big Data initiatives to ensure optimal use of the institute's limited resources, said NCI Director Norman “Ned” Sharpless at his first joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors.
After 20 years at Ohio State University, Michael Caligiuri is moving on.
Michael Caligiuri was named physician-in-chief of City of Hope and president of City of Hope National Medical Center.
FDA approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of renal cell carcinoma returning after nephrectomy.
FDA granted a regular approval to obinutuzumab (Gazyva) in combination with chemotherapy, followed by obinutuzumab monotherapy in patients achieving at least a partial remission, for the treatment of adult patients with previously untreated stage II bulky, III, or IV follicular lymphoma.
FDA has granted regular approval to dasatinib (Sprycel) for the treatment of pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
